Act now or later? Economics of malaria resistance

Research output: Contribution to journalArticlepeer-review

50 Scopus citations

Abstract

In the past, malaria control efforts in sub-Saharan Africa have relied on a combination of vector control with effective treatment using chloroquine. With increasing resistance to chloroquine, attention has now turned to alternative treatment strategies to replace this failing drug. Some countries have already changed their official first-line treatment to sulfadoxine-pyrimethamine, while others are contemplating a switch to artemisinin-based combination treatments (ACTs). Although there are strong theoretical arguments in favor of switching to ACTs, the validity of these arguments in the face of financial constraints has not been previously analyzed. In this report, we use a bioeconomic model of malaria transmission and evolution of drug resistance to examine questions of optimal treatment strategy and coverage when drug resistance places an additional constraint on choices available to the policymaker.

Original languageEnglish (US)
Pages (from-to)187-195
Number of pages9
JournalAmerican Journal of Tropical Medicine and Hygiene
Volume71
Issue number2 SUPPL.
DOIs
StatePublished - Aug 2004
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Parasitology
  • Virology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Act now or later? Economics of malaria resistance'. Together they form a unique fingerprint.

Cite this